LexDanaLexDanabeta
Inventor

Patrick M. Hughes

Inventor
Aliso Viejo, CA, US

Overview

94→
Patents
1982–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 94 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
A61LMethods or apparatus for sterilising materials or objects in general10%
A61FFilters implantable into blood vessels9%
C08LCompositions of macromolecular compounds5%
Y02ATechnologies for adaptation to climate change4%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry4%
Y10TTechnical subjects covered by former us classification3%
C12YEnzymes2%
G11BInformation storage based on relative movement between record carrier and transducer2%
PatentTitleYear
11,078,262High viscosity macromolecular compositions for treating ocular conditions202111,065,428Microneedle array with active ingredient202110,864,218Hypotensive lipid-containing biodegradable intraocular implants and related methods202010,792,345Dermal filler202010,682,361Sustained release bimatoprost, bimatoprost analogs, prostamides and prostaglandins for fat reduction202010,668,081Prostamide-containing intraocular implant202010,653,621Biodegradable drug delivery systems for the sustained release of proteins202010,463,772Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof201910,406,168Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods201910,398,707Hypotensive lipid-containing biodegradable intraocular implants and related implants201910,363,214Method for treating atrophic age related macular degeneration201910,328,086Hypotensive lipid-containing biodegradable intraocular implants and related methods201910,201,641Sustained release intraocular implants and methods for treating ocular vasculopathies201910,076,492Biodegradable intravitreal tyrosine kinase implants201810,064,872Oil-in-water method for making polymeric implants containing a hypotensive lipid20189,943,576Formulations of biologics for intravesical instillation20189,889,142'Prostamide-containing intraocular implant'20189,775,846'Hypotensive lipid-containing biodegradable intraocular implants and related implants'20179,750,751'Hypotensive lipid-containing biodegradable intraocular implants and related methods'20179,707,238'Oil-in-water method for making polymeric implants containing a hypotensive lipid'20179,669,039'Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods'20179,622,957'Dermal filler'20179,572,859'Compositions and methods for localized therapy of the eye'20179,504,653'Microsphere drug delivery system for sustained intraocular release'20169,498,457'Hypotensive prostamide-containing biodegradable intraocular implants and related implants'20169,393,223'Hypotensive lipid-containing biodegradable intraocular implants and related methods'20169,326,949'Method of making oil-in-oil emulsified polymeric implants containing a hypotensive lipid'20169,289,413'Prostamide-containing intraocular implant'20169,233,070'Biodegradable intravitreal tyrosine kinase implants'20169,161,970'Dermal filler'20159,161,938'Sustained release intraocular implants and methods for treating ocular vasculopathies'20159,144,543'Sustained release intraocular implants and methods for preventing retinal dysfunction'20159,101,583'Microparticles manufactured in an oil-in-water process comprising a prostamide'20159,056,045'Intraocular biodegradable microspheres'20159,050,336'Botulinum toxin formulation'20159,044,477'Botulinum toxin formulation'20158,999,397'Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods'20158,968,766'Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods'20158,969,415'Intraocular drug delivery systems'20158,911,767'Hypotensive lipid-containing biodegradable intraocular implants and related methods'20148,900,622'Hypotensive lipid-containing biodegradable intraocular implants and related methods'20148,821,870'Method for treating atrophic age related macular degeneration'20148,771,745'Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof'20148,722,097'Oil-in-water method for making polymeric implants containing a hypotensive lipid'20148,673,341'Intraocular pressure reduction with intracameral bimatoprost implants'20148,637,571'Compositions and methods for the intraocular transport of therapeutic agents'20148,637,068'Hypotensive prostamide-containing biodegradable intraocular implants and related methods'20148,609,144'Sustained release intraocular implants and methods for preventing retinal dysfunction'20138,591,885'Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems'20138,580,292'Sustained release intraocular implants and methods for treating ocular vasculopathies'20138,571,802'Method for determining optimum intraocular locations for drug delivery systems'20138,529,927'Alpha-2 agonist polymeric drug delivery systems'20138,512,738'Biodegradable intravitreal tyrosine kinase implants'20138,506,986'Sustained release intraocular implants and methods for treating ocular vasculopathies'20138,501,187'Stabilized biodegradable neurotoxin implants'20138,481,069'Tyrosine kinase microspheres'20138,465,778'Method of making tyrosine kinase microspheres'20138,455,656'Kinase inhibitors'20138,445,027'Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and prostamide'20138,425,929'Sustained release intraocular implants and methods for preventing retinal dysfunction'20138,409,607'Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods'20138,404,267'Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods'20138,383,825'Kinase inhibitors'20138,293,210'Sustained release intraocular implants and methods for preventing retinal dysfunction'20128,293,741'Intraocular implants and methods for improving vision'20128,206,736'Hypotensive lipid-containing biodegradable intraocular implants and related methods'20128,206,737'Hypotensive lipid-containing biodegradable intraocular implants and related methods'20128,143,410'Kinase inhibitors'20128,007,828'Stabilized biodegradable neurotoxin implants'20117,993,634'Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods'20117,931,909'Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates'20117,799,336'Hypotensive lipid-containing biodegradable intraocular implants and related methods'20107,771,742'Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods'20107,749,530'Kinase inhibitors'20107,714,024'Compositions and methods for the intraocular transport of therapeutic agents'20107,691,381'Stabilized biodegradable neurotoxin implants'20107,589,057'Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems'20097,384,648'Implant device with a retinoid for improved biocompatibility'20087,179,482'Implant device with a retinoid for improved biocompatibility'20076,743,437'Implant device with a retinoid for improved biocompatibility'20046,537,568'Implant device with a retinoid for improved biocompatibility'20036,455,062'Implant device with a retinoid for improved biocompatibility'20026,306,426'Implant device with a retinoid for improved biocompatibility'20016,110,485'Sterile bioerodible implant device with a retinoid for improved biocompatability'20006,074,661'Sterile bioerodible occular implant device with a retinoid for improved biocompatability'20005,486,971'Central hubs for flexible magnetic data discs formed of magnetically soft polyacetal compositions'19965,214,555'Central hubs for flexible magnetic data discs formed of magnetically soft polyacetal compositions'19935,212,614'Flexible magnetic disc cassettes with separable cassette cases'19935,200,871'Flexible magnetic disc cassettes with integrally molded drag fingers'19935,177,656'Flexible magnetic disc cassettes with integrally molded wear button'19935,164,871'Shutters with integrally molded spring elements for flexible magnetic disc cassettes'19924,886,849'Butene-1 molding resin blends'19894,354,004'Film compositions from olefin polymer blends'19824,316,970'Blends of butene-1-ethylene copolymer and polypropylene'1982

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1982Based in Houston, TX, US· patent location history
1989–1993Based in Clinton, NJ, US· patent location history
1996Based in Plano, TX, US· patent location history
2000–2021Based in Aliso Viejo, CA, US· patent location history
2002–2021Patents assigned to ALLERGAN INC (82)· patent assignee history
2012–2021Patents assigned to HUGHES PATRICK M (30)· patent assignee history
2012–2015Patents assigned to SPADA LON T (7)· patent assignee history
2013–2015Patents assigned to BLANDA WENDY M (7)· patent assignee history
2013–2015Patents assigned to ROBINSON MICHAEL R (7)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ALLERGAN INC822002–2021
HUGHES PATRICK Mself302012–2021
BLANDA WENDY M72013–2015
ROBINSON MICHAEL R72013–2015
SPADA LON T72012–2015
Locations
LocationPatentsSpan
Aliso Viejo, California, US852000–2021
Clinton, New Jersey, US61989–1993
Houston, Texas, US21982
Plano, Texas, US11996